Product
Fycompa
Aliases
Perampanel
Name
Fycompa
INN Name
perampanel
FDA Approved
Yes
3 clinical trials
1 organization
2 indications
1 document
Indication
EpilepsyIndication
Catamenial EpilepsyClinical trial
An Open-label, Balanced, Randomized, Two Treatment, Two Sequence, Two Period, Two Way Cross-over, Single Dose Bioequivalence Study of Perampanel Tablets 12 mg of Humanis Sağlık A.Ş., Turkey and Fycompa 12 mg Film-coated Tablets of Eisai GmbH Edmund-Rumpler-Straße 3 60549 Frankfurt am Main Germany in Normal, Healthy, Adult, Human Subjects Under Fasting ConditionStatus: Completed, Estimated PCD: 2023-09-20
Clinical trial
An Open-label, Balanced, Randomized, Two Treatment, Two Sequence, Two Period, Two Way Cross-over, Single Dose Bioequivalence Study of Perampanel Tablets 10 mg of Humanis Sağlık A.Ş., Turkey and Fycompa 10 mg Film-coated Tablets of Eisai GmbH Edmund-Rumpler-Straße 3 60549 Frankfurt am Main Deutschland in Normal, Healthy, Adult, Human Subjects Under Fasting ConditionStatus: Completed, Estimated PCD: 2023-11-26
Clinical trial
Pilot Study of Add-On Fycompa (Perampanel)Treatment for Catamenial EpilepsyStatus: Recruiting, Estimated PCD: 2023-12-15
Document
DailyMed Label: FycompaOrganization
Catalyst Pharmaceuticals, Inc.